Status:
RECRUITING
Amyotrophic Lateral Sclerosis Registry in Thailand
Lead Sponsor:
Chulalongkorn University
Conditions:
ALS (Amyotrophic Lateral Sclerosis)
Eligibility:
All Genders
Brief Summary
This is a prospective, observational, multicenter registry designed to collect comprehensive clinical, genetic, and outcome data from patients diagnosed with amyotrophic lateral sclerosis (ALS) across...
Detailed Description
Amyotrophic lateral sclerosis (ALS) is a fatal neurodegenerative disorder that affects upper and lower motor neurons, leading to progressive muscle weakness, disability, and respiratory failure. Despi...
Eligibility Criteria
Inclusion
- Diagnosis of ALS according to El Escorial or Gold Coast criteria
- Age ≥ 18 years
- Ability and willingness to provide informed consent
Exclusion
- Patients unwilling to provide informed consent
- Patients with alternative diagnoses mimicking ALS
Key Trial Info
Start Date :
March 1 2025
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
December 31 2030
Estimated Enrollment :
100 Patients enrolled
Trial Details
Trial ID
NCT07175935
Start Date
March 1 2025
End Date
December 31 2030
Last Update
September 16 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
King Chulalongkorn Memorial hospital, The Thai Red Cross Society
Pathum Wan, Bangkok, Thailand, 10330